]>
IRCT20180407039214N1 IRCT 2018-06-19 Khoram-Abad University of Medical Sciences The effect of Rhus Coriaria on serum levels of lipids The effect of Rhus Coriaria(Sumac) on serum levels of lipids, uric acid and Body Mass Index(BMI) in patients under hemodialysis 2018-07-23 anticipated 120 Complete https://irct.ir/trial/31691 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Stratified blocks are randomly divided into three groups, while gender, age, and base lipids are matched. N/A hemodialysis. Intervention 1: Intervention group: . Intervention 2: Intervention group: . Intervention 3: Control group: . Yes - There is a plan to make this available What will be shared: Individual data of the participants and the whole potential data are the primary consequences and after the unidentifiable individuals can be shared. When: 6 months after printing results To whom: Academic, scientific, medical, and therapeutic establishments Conditions: For review studies, systematic review and meta-analysis Where to obtain: Tahere Toulabi toulabi_t@yahoo.com 00986633120140 00989161613969 How to obtain: After the correspondence and explain the reason for the need for data, the average will be sent after a week's data. Comments:
public Fereshteh Allahnouri
Faculty of Nursing and Midwifery, Kmalalvand, 5 km of KhorramAbad-Boroujerd Road
KhorramAbad Iran (Islamic Republic of) 381351698 +98 66 3312 0140 f.alahnoori95@gmail.com Khoram-Abad University of Medical Sciences scientific Tahereh Toulabi
Faculty of Nursing and Midwifery, Kmalalvand, 5 km of KhorramAbad-Boroujerd Road
KhorramAbad Iran (Islamic Republic of) 381351698 +98 66 3312 0140 toulabi_t@yahoo.com Khoram-Abad University of Medical Sciences Iran (Islamic Republic of) The age range is 70-35 years Cure for chronic renal failure according to a doctor's diagnosis Start at least three months hemodialysis Do three hemodialysis per week Nephrologist confirmation for patient entry to study Access to the patient 3 months after entering the study The desire to participate in research with informed consent 35 years 70 years Both Any sensitivity and allergy to Sumac and their products Mental disorders pain and acute illness Excessive weight loss and obesity 40 ≥ BMI ≥ 19 Follow Weight Loss Diets Under Dieticians History of obstructive and inflammatory diseases of the stomach and intestines Severe constipation Pregnancy and lactation Smoking and drinking alcohol Cold Getting more than one lipid-lowering drug (Jim Fiberozyl, etc.) Get a Uric acid-lowering drug Having regular and intense activity Z49.0 Preparatory care for renal dialysis Treatment - Drugs Treatment - Drugs Placebo Intervention group: Intervention group: Control group: Serum levels of lipids. Timepoint: Before the intervention, 6 weeks after the intervention and 12 weeks after the intervention. Method of measurement: Laboratory tests. Uric acid. Timepoint: Before the intervention, 6 weeks after the intervention and 12 weeks after the intervention. Method of measurement: Laboratory tests. Body Mass Index. Timepoint: Before the intervention, 6 weeks after the intervention and 12 weeks after the intervention. Method of measurement: By dividing body weight (kg) by height (m * 2). Khoram-Abad University of Medical Sciences Approved 2018-03-12 Ethics committee of Lorestan University of Medical Sciences Deputy of Research and Technology of Lorestan University of Medical Sciences, Kamalvand, 5 km Khorramabad - Boroujerd Road KhorramAbad Lorestan Iran (Islamic Republic of)